Afognak Native Corporation

Anchorage, AK Business servicesNAICS 561490

Self-funded health planPlan year 2025Renews January
2,538Participants-7% vs. prior year
$6.0MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#1 of 2Business services in AKBy participants

Overview

Afognak Native Corporation sponsors a self-funded health plan that covered 2,538 participants in plan year 2025, down 7% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
2,538 · prior year 2,728
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Afognak Native Corporation Health and Welfare Plan, plan 501 (2,538 participants)
Stop-loss carrier
Lifewise Assurance Company
Broker compensation
$179K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disability

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Cigna Health and Life Insurance CompanyMedical, Dental149$2.4M$98K
Hartford Life and AccidentAd&d-Bas, Ad&d-Supp, Life, Long-term disability1,881$1.3M$52K
Metropolitan Life Insurance CompanyDental, Vision1,154$1.2M$123
Lifewise Assurance CompanyStop-loss1,166$619K—
Premera Blue Cross Blue Shield of Alaska, Inc.Medical, Prescription drug1,809$498K—
Reliastar Life Insurance CompanyAccident, Critical Illness, Hospital Confinement458$204K$27K
Arag Insurance CompanyLegal580$50K$2K
Zurich American Insurance CompanyAD&D364$5K$1K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$6.0M/ year

Estimated prescription spend: 2,538 participants × $2,371 national average per member. Usually higher once dependents are counted.

$156K–$386K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$46K–$114K
Lower-cost therapeutic alternatives$67K–$140K
Generic pricing vs. actual cost$29K–$87K
PBM contract terms$15K–$45K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Afognak Native Corporation
Sponsor EIN
92-0047145
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 92-0047145 in the Department of Labor's EFAST2 Form 5500 search.

About this data

Source: Afognak Native Corporation's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Afognak Native Corporation.

Request a correction · Methodology